Tata India Pharma & Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 19-11-2024
NAV ₹29.46(R) +0.93% ₹33.92(D) +0.93%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 39.2% 19.26% 26.43% 19.49% -%
LumpSum (D) 41.24% 21.04% 28.33% 21.37% -%
SIP (R) 10.61% 28.69% 24.43% 23.02% -%
SIP (D) 12.32% 30.58% 26.27% 24.85% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.88 0.5 0.85 4.32% 0.15
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.08% -14.79% -14.52% 0.9 10.03%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 19-11-2024

Scheme Name NAV Rupee Change Percent Change
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option 29.46
0.2700
0.9300%
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option 29.46
0.2700
0.9300%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 29.46
0.2700
0.9300%
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option 33.92
0.3100
0.9300%
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option 33.92
0.3100
0.9300%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 33.92
0.3100
0.9300%

Review Date: 19-11-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed six return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Six return parameters of the fund are below average in the category, which are listed below:
      • 1Y Return %
      • 5Y Return %
      • 3Y Return %
      • 6M Return %
      • 3M Return %
      • 1M Return %
  2. Risk: The threat of not realizing projected profits or even facing financial loss due to different issues is known as risk. For Tata India Pharma & Healthcare Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: one risk parameter in the lowest 25% in the category, which is listed below.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.03 %.
    2. Below Average but Above the Lowest 25%: Tata India Pharma & Healthcare Fund has one risk parameter that is below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.08 %.
    3. Above Average: Tata India Pharma & Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated four risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: Tata India Pharma & Healthcare Fund has four risk-adjusted performance parameters of the fund that are in the this group of the category.
      • Sharpe Ratio: Tata India Pharma & Healthcare Fund has a Sharpe Ratio of 0.88 compared to the category average of 0.85.
      • Sterling Ratio: Tata India Pharma & Healthcare Fund has a Sterling Ratio of 0.85 compared to the category average of 0.78.
      • Sortino Ratio: Tata India Pharma & Healthcare Fund has a Sortino Ratio of 0.5 compared to the category average of 0.47.
      • Treynor Ratio: Tata India Pharma & Healthcare Fund has a Treynor Ratio of 0.15 compared to the category average of 0.14.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -4.39
-3.29
-6.13 | -1.38 10 | 13 Average
3M Return % -1.12
1.96
-4.87 | 6.68 10 | 13 Average
6M Return % 14.36
18.30
11.91 | 24.73 10 | 13 Average
1Y Return % 39.20
42.10
34.98 | 50.25 8 | 11 Average
3Y Return % 19.26
19.81
16.87 | 23.20 5 | 8 Average
5Y Return % 26.43
27.82
23.59 | 30.75 7 | 8 Poor
7Y Return % 19.49
19.20
18.34 | 20.52 2 | 4 Good
1Y SIP Return % 10.61
11.42
-16.11 | 26.02 7 | 11 Average
3Y SIP Return % 28.69
29.69
26.71 | 34.29 5 | 8 Average
5Y SIP Return % 24.43
25.28
22.04 | 28.06 6 | 8 Average
7Y SIP Return % 23.02
23.52
23.02 | 24.40 4 | 4 Poor
Standard Deviation 15.08
15.31
14.31 | 15.96 3 | 8 Good
Semi Deviation 10.03
10.45
10.03 | 10.78 1 | 8 Very Good
Max Drawdown % -14.52
-16.50
-18.92 | -14.27 2 | 8 Very Good
VaR 1 Y % -14.79
-16.74
-18.91 | -14.68 2 | 8 Very Good
Average Drawdown % -4.07
-5.03
-7.25 | -3.98 3 | 8 Good
Sharpe Ratio 0.88
0.85
0.66 | 1.10 3 | 8 Good
Sterling Ratio 0.85
0.78
0.66 | 0.96 3 | 8 Good
Sortino Ratio 0.50
0.47
0.36 | 0.59 3 | 8 Good
Jensen Alpha % 4.32
3.31
-0.30 | 7.34 3 | 8 Good
Treynor Ratio 0.15
0.14
0.11 | 0.19 4 | 8 Good
Modigliani Square Measure % 22.55
21.86
18.21 | 26.49 3 | 8 Good
Alpha % 2.62
1.69
-1.06 | 4.46 3 | 8 Good
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -4.28 -3.19 -6.01 | -1.30 10 | 13
3M Return % -0.76 2.29 -4.48 | 7.04 10 | 13
6M Return % 15.18 19.06 12.84 | 25.80 10 | 13
1Y Return % 41.24 43.86 36.19 | 52.14 8 | 11
3Y Return % 21.04 21.27 18.64 | 24.29 4 | 8
5Y Return % 28.33 29.43 25.54 | 32.68 7 | 8
7Y Return % 21.37 20.57 19.64 | 21.60 2 | 4
1Y SIP Return % 12.32 12.87 -14.86 | 27.66 7 | 11
3Y SIP Return % 30.58 31.23 28.48 | 35.44 5 | 8
5Y SIP Return % 26.27 26.80 23.81 | 29.20 5 | 8
7Y SIP Return % 24.85 24.87 24.43 | 25.70 2 | 4
Standard Deviation 15.08 15.31 14.31 | 15.96 3 | 8
Semi Deviation 10.03 10.45 10.03 | 10.78 1 | 8
Max Drawdown % -14.52 -16.50 -18.92 | -14.27 2 | 8
VaR 1 Y % -14.79 -16.74 -18.91 | -14.68 2 | 8
Average Drawdown % -4.07 -5.03 -7.25 | -3.98 3 | 8
Sharpe Ratio 0.88 0.85 0.66 | 1.10 3 | 8
Sterling Ratio 0.85 0.78 0.66 | 0.96 3 | 8
Sortino Ratio 0.50 0.47 0.36 | 0.59 3 | 8
Jensen Alpha % 4.32 3.31 -0.30 | 7.34 3 | 8
Treynor Ratio 0.15 0.14 0.11 | 0.19 4 | 8
Modigliani Square Measure % 22.55 21.86 18.21 | 26.49 3 | 8
Alpha % 2.62 1.69 -1.06 | 4.46 3 | 8
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.93 ₹ 10,093.00 0.93 ₹ 10,093.00
1W -1.43 ₹ 9,857.00 -1.40 ₹ 9,860.00
1M -4.39 ₹ 9,561.00 -4.28 ₹ 9,572.00
3M -1.12 ₹ 9,888.00 -0.76 ₹ 9,924.00
6M 14.36 ₹ 11,436.00 15.18 ₹ 11,518.00
1Y 39.20 ₹ 13,920.00 41.24 ₹ 14,124.00
3Y 19.26 ₹ 16,960.00 21.04 ₹ 17,731.00
5Y 26.43 ₹ 32,298.00 28.33 ₹ 34,807.00
7Y 19.49 ₹ 34,787.00 21.37 ₹ 38,791.00
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 10.61 ₹ 12,681.38 12.32 ₹ 12,789.26
3Y ₹ 36000 28.69 ₹ 54,415.84 30.58 ₹ 55,810.58
5Y ₹ 60000 24.43 ₹ 109,936.14 26.27 ₹ 114,898.74
7Y ₹ 84000 23.02 ₹ 190,870.85 24.85 ₹ 203,635.49
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Tata India Pharma & Healthcare Fund NAV Regular Growth Tata India Pharma & Healthcare Fund NAV Direct Growth
19-11-2024 29.4644 33.9246
18-11-2024 29.1938 33.6117
14-11-2024 29.4436 33.894
13-11-2024 29.488 33.9437
12-11-2024 29.8925 34.408
11-11-2024 30.1327 34.6831
08-11-2024 30.4869 35.0866
07-11-2024 30.5683 35.179
06-11-2024 30.9102 35.571
05-11-2024 30.645 35.2644
04-11-2024 30.6891 35.3137
31-10-2024 30.711 35.3335
30-10-2024 30.2827 34.8394
29-10-2024 30.3816 34.9518
28-10-2024 30.5724 35.1699
25-10-2024 30.2073 34.7457
24-10-2024 30.3667 34.9277
23-10-2024 30.0698 34.5848
22-10-2024 30.3107 34.8605
21-10-2024 30.8185 35.4431

Fund Launch Date: 04/Dec/2015
Fund Category: Pharma Fund
Investment Objective: The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Fund Description: A) Pharmaceuticals and Healthcare services sector oriented Fund b) Ideal for investors seeking focused investments in Health service and Medicine realated sectors
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.